Osteoporosis natural history

Jump to navigation Jump to search

Osteoporosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Osteoporosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Life Style Modification
Pharmacotherapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Osteoporosis natural history On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Osteoporosis natural history

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Osteoporosis natural history

CDC on Osteoporosis natural history

Osteoporosis natural history in the news

Blogs on Osteoporosis natural history

Directions to Hospitals Treating Osteoporosis

Risk calculators and risk factors for Osteoporosis natural history

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

Overview

Osteoporosis can be complicated by the development of fractures. The prognosis is generally good and mortality from the disease will depend on the the type of fracture. The major type of fractures contributing to mortality in these patients are vertebral fractures and hip fractures.

Natural History

The symptoms of the disease typically develop in the sixth decade of life. The risk of getting osteoporosis increases proportionately with age. DXA bone densitometry is recommended every 2–3 years as a screening tool. The outcome is usually good with appropriate and timely usage of medications and with calcium and / or vitamin D supplementation. Persons who are elderly, who are taking medications which deplete calcium, who are thin or of caucasian or asian race and female, are at higher risk for osteoporosis. Having osteopenia, which is decreased mineral bone density, is also a risk factor for osteoporosis.

Complications

Disease can be complicated by the development of:

  • Fractures - the hip and the vertebrae are among the most frequent sites of fracture
Pathologic fractures

Prognosis

  • The prognosis of the disease is good if the decrease in bone mass density is identified early, and the appropriate anti-osteoporotic medications are started.
  • DVT caused by prolonged immobility from hip fractures is associated with a poorer prognosis among patients with disease.
Hip fractures per 1000 patient-years[2]
WHO category Age 50-64 Age > 64 Overall
Normal 5.3 9.4 6.6
Osteopenia 11.4 19.6 15.7
Osteoporosis 22.4 46.6 40.6
  • The lifetime fracture risk in caucasian women is 18% for hip fractures, 16% for spine fractures, and 16% for wrist fractures. In men the same fractures account for 6%, 5%, and 3% respectively.
  • More than half of all women, and one third of all men, have osteoporotic fractures in their lifetime.
  • Men have a higher mortality from fractures when compared to women.
  • The 6-month mortality rate following hip fracture is approximately 13.5%.
  • Vertebral fractures, while having a smaller impact on mortality than hip fractures, can lead to severe chronic pain of neurogenic origin which is difficult to treat, as well as postural deformity.

References

  1. Brenneman SK, Barrett-Connor E, Sajjan S, Markson LE, Siris ES (2006). "Impact of recent fracture on health-related quality of life in postmenopausal women". J. Bone Miner. Res. 21 (6): 809–16. doi:10.1359/jbmr.060301. PMID 16753011.
  2. Cranney A, Jamal SA, Tsang JF, Josse RG, Leslie WD (2007). "Low bone mineral density and fracture burden in postmenopausal women". CMAJ. 177 (6): 575–80. doi:10.1503/cmaj.070234. PMID 17846439.


Template:WH Template:WS